The evidence leans constructive5 supporting, 1 against, 0 worth knowing
Supporting
trading 9% above its 200-day average
sitting at 100% of its 52-week range, with little overhead supply from trapped buyers
matches made a new 52-week high today, which has beaten the market by +1.03 points over 20 sessions across 9,118 past signals
4 of the scans it matches have a positive measured record
5 independent kinds of evidence agree today, which is uncommon
Against
2 of the scans it matches have historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close below 142, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
9 of 47 matched on 2026-08-21
CANHLIFE matches 9 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Management filings were typically -0.01pt vs the market over the next 5 sessions (n=1,988) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue rose in 2 of the last 3 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · standalone
4,347
32
—
—
—
Q4 FY26
2026-03-31 · standalone
1,268
39
—
—
—
Q3 FY26
2025-12-31 · standalone
4,273
31
—
—
—
Q2 FY26
2025-09-30 · standalone
2,349
45
—
—
—
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+6.4%
Versus 200-day average+9.5%
Below 52-week high+0.0%
Above 52-week low+42.9%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)60.3
Higher closes in last 55 of 5
Six-month return+5.78%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.